FDA Updates Labeling on Febrile Seizure Risks i...

By João L. Carapinha

January 19, 2026

FDA Labeling Mandate on Febrile Seizure Risks In a significant update to vaccine safety protocols, the U.S. Food and Drug Administration (FDA) has required pediatric influenza vaccines t...
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic...
Health Misinformation Autism: The Dangers of Politicized Science in Vaccine a...
NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Su...
Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascul...
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM M...
Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidiscipl...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival